Zão Ana, Magalhães Sandra, Santos Mário
Serviço de Medicina Física e de Reabilitação, Centro Hospitalar do Porto, Porto, Portugal.
Serviço de Medicina Física e de Reabilitação, Centro Hospitalar do Porto, Porto, Portugal.
Rev Port Cardiol (Engl Ed). 2019 Feb;38(2):143-158. doi: 10.1016/j.repc.2018.05.019. Epub 2019 Mar 14.
Cardiovascular disease (CVD) is the leading cause of death in developed countries and disproportionately affects older adults. Frailty is a complex clinical syndrome with multiple causes and contributing factors in which there is increased vulnerability when exposed to a minor stressor and increased risk for adverse outcomes, such as disability, hospitalization and mortality. Frailty is an important prognostic factor in patients with CVD, and so identifying this feature when assessing these patients may help to individually tailor cardiovascular treatment. The first step is to identify frailty. Several tools have been validated as screening methods for frailty. However, they diverge with regard to complexity, nature, feasibility and the outcome they can predict. The aim of this review is to describe the available screening tools for frailty and to examine their usefulness in patients with CVD.
心血管疾病(CVD)是发达国家的主要死因,且对老年人的影响尤为严重。衰弱是一种复杂的临床综合征,有多种病因和促成因素,在接触轻微应激源时易感性增加,出现残疾、住院和死亡等不良后果的风险也增加。衰弱是心血管疾病患者的一个重要预后因素,因此在评估这些患者时识别这一特征可能有助于个性化定制心血管治疗方案。第一步是识别衰弱。有几种工具已被验证可作为衰弱的筛查方法。然而,它们在复杂性、性质、可行性以及所能预测的结果方面存在差异。本综述的目的是描述现有的衰弱筛查工具,并探讨它们在心血管疾病患者中的实用性。